vTv Therapeutics Inc

Public biopharmaceutical company valuations have taken a sharp turn into the red in the US during the past month, plunging the industry’s market for initial public offering into a drought. This trend

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Roche Exits Gene Therapy Delivery Pact

The US Food and Drug Administration breakthrough therapy designation program has granted a dozen new BTDs in 2021, including designations for seven novel agents. As could be expected, oncology was the

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. GSK Becomes Surface Oncology’s Latest B